This is further corroborated by recent results of brentuximab+chemotherapy combinations in newly diagnosed ALK+ ALCL patients [4,51] and promising in vitro data on crizotinib+brentuximab association [52]. Here, ALK is linked to anaplastic large cell lymphoma.